1. Home
  2. SSKN vs DWTX Comparison

SSKN vs DWTX Comparison

Compare SSKN & DWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSKN
  • DWTX
  • Stock Information
  • Founded
  • SSKN 1989
  • DWTX 2012
  • Country
  • SSKN United States
  • DWTX United States
  • Employees
  • SSKN N/A
  • DWTX N/A
  • Industry
  • SSKN Medical/Dental Instruments
  • DWTX
  • Sector
  • SSKN Health Care
  • DWTX
  • Exchange
  • SSKN Nasdaq
  • DWTX NYSE
  • Market Cap
  • SSKN 9.7M
  • DWTX 9.2M
  • IPO Year
  • SSKN 2005
  • DWTX N/A
  • Fundamental
  • Price
  • SSKN $2.25
  • DWTX $4.79
  • Analyst Decision
  • SSKN Strong Buy
  • DWTX Strong Buy
  • Analyst Count
  • SSKN 1
  • DWTX 1
  • Target Price
  • SSKN $6.00
  • DWTX $10.00
  • AVG Volume (30 Days)
  • SSKN 19.6K
  • DWTX 26.9K
  • Earning Date
  • SSKN 08-13-2025
  • DWTX 08-14-2025
  • Dividend Yield
  • SSKN N/A
  • DWTX N/A
  • EPS Growth
  • SSKN N/A
  • DWTX N/A
  • EPS
  • SSKN N/A
  • DWTX N/A
  • Revenue
  • SSKN $33,620,000.00
  • DWTX N/A
  • Revenue This Year
  • SSKN $3.31
  • DWTX N/A
  • Revenue Next Year
  • SSKN $9.67
  • DWTX N/A
  • P/E Ratio
  • SSKN N/A
  • DWTX N/A
  • Revenue Growth
  • SSKN 3.30
  • DWTX N/A
  • 52 Week Low
  • SSKN $2.10
  • DWTX $1.62
  • 52 Week High
  • SSKN $3.80
  • DWTX $29.28
  • Technical
  • Relative Strength Index (RSI)
  • SSKN 42.40
  • DWTX N/A
  • Support Level
  • SSKN $2.34
  • DWTX N/A
  • Resistance Level
  • SSKN $2.53
  • DWTX N/A
  • Average True Range (ATR)
  • SSKN 0.19
  • DWTX 0.00
  • MACD
  • SSKN -0.00
  • DWTX 0.00
  • Stochastic Oscillator
  • SSKN 1.54
  • DWTX 0.00

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

About DWTX DOGWOOD THERAPEUTICS INC

Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

Share on Social Networks: